GV1001, a fragment of human telomerase reverse transcriptase, with high binding affinity with the prediction of binding to GnRHR, was a potential novel GnRHR ligand capable of inhibiting PCa metastasis via the Gαs/cAMP pathway (Kim et al., 2021). The gene discussed is GNRHR; the disease is posterior cortical atrophy.